Could a new peptide treatment help treat spinal cord injury and more?
Big news today in the area of spinal cord injury. A group of Case Western Reserve scientists have recently been working with a new peptide treatment that has garnished new hopes in treating spinal cord injury.
The peptide is called intercellular sigma peptide (ISP), and in initial animal testing, this peptide has shown to reactivate paralyzed muscle fibers with more than a 80% success rate. Nearly all the animals involved in the testing, regained at least one lost ability related to the injury.
The peptide appears to work by allowing nerve fibers to overcome the scarring from the injury that blocks their regrowth. While more testing is still needed, this surely exhibits the advancements that could soon be on the horizon. Not only for spinal cord injury, but any disease or injury resulting in limitations due to scarring. Such potential treatments include, heart attack patients and those fighting MS.
To read the full article, please visit: